A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

Over 80% of these fatalities result from heart attacks and strokes. December is notorious for being the biggest month for heart attacks, with one of the most dangerous being the widowmaker heart ...

A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...

Increased risk seen for adverse cardiovascular events, including myocardial infarction, stroke, heart failure, mortality ...

For patients with ACS undergoing DES implantation, de-escalating DAPT to P2Y12 inhibitor monotherapy is associated with lower bleeding risk.

Gasherbrum Bio Inc. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, dyslipidemia, schizophrenia, hypertension, obesity, ...

In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.

The following is a summary of “Continuous quality improvement for prehospital STEMI improved triage rates and achievement of ...

Poor performance on quality metrics carried greater risk of in-hospital mortality no matter where patients initially ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.